- Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist. Von Lubitz, D.K., Beenhakker, M., Lin, R.C., Carter, M.F., Paul, I.A., Bischofberger, N., Jacobson, K.A. Eur. J. Pharmacol. (1996)









